Clinical Trials Arena: Alphyn gears up for Phase IIb trial for dermatitis treatment
Clinical Trials Arena: Alphyn gears up for Phase IIb trial for dermatitis treatment by Abigail Beaney NEWS PROVIDED BY Alphyn Biologics March 8, 2024 Maryland-based Alphyn Biologics announced that the second cohort in its Phase IIa trial evaluating zabalafin hydrogel (AB-101a) in AD and infected AD skin met all its endpoints. CEO Neal Koller said…